2024 USA Respiratory Disease Testing Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

About This Report

This new 283-page report presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs.

The report is available by section, and can be customized to specific information needs and budget.

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used 
   for microbiology testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies, 
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.

Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. Country Analysis: Market Size, Growth and Major
Suppliers Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference

4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare

- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako

2024 Vietnam Coagulation Testing Market

2024 Vietnam Coagulation Testing Market--Hemostasis Analyzers and Consumables--2023 Supplier Shares, 2023-2028 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers--Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests--Growth Strategies,

USD 2500 View Report

2024 Venezuela Coagulation Testing Market

2024 Venezuela Coagulation Testing Market--Hemostasis Analyzers and Consumables--2023 Supplier Shares, 2023-2028 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers--Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests--Growth Strategies,

USD 2500 View Report

2024 USA HIV/AIDS Diagnostic Testing Market: Shares and Segment Forecasts--HIV 1/2, Combo, Ag, NAT, Western Blot, Other Confirmatory Tests

This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and

USD 1850 View Report

2024 USA Sexually-Transmitted Disease (STD) Market: Shares and Segment Forecasts--Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), Syphilis

About This ReportThis new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,

USD 1850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available